Hound

**MEMBERS ONLY**SIGN UP NOW*** Job Description Company Overview Founded in 1984, **MEMBERS ONLY**SIGN UP NOW*** & Research Institute is the largest independent medical oncology/hematology practice in the United States. With over 200 physicians, based in 100 locations across Florida, we are committed to providing world-class cancer care in community-based settings close to home. Our 3000 team members enjoy: Work/Life balance \u2013 many locations have no weekend and/or night shift hours Competitive compensation Comprehensive benefits package including: Medical, dental, vision, life, and disability insurance Paid time off Holiday pay Tuition reimbursement CEU hours 401(k) with company match Our lab in Ft. Myers is searching for a PRN Flow Cytometry Technologist to join our team! Responsibilities This is a PRN position. Weekly hours can very between 0-19. The Flow Cytometry Technologist is responsible for daily specimen processing in the clinical flow cytometry laboratory. Communicates withstaff physicians and other staff employees regarding patient specimens. Works with management personnel to ensure efficient and technically correct systems and procedures in the clinical cytometry laboratory that includes QA/QC of reagents,instrumentation, proficiency testing, etc. Qualifications Bachelor's Degree in Clinical Lab, Chemistry, Biology or related field and completed an accredited medical technology program and have greater than 5 years clinical lab experience. Some experience in Flow Cytometry preferred, but not required. ","datePosted":"2018-01-03T16:51:12.789Z","title":"UNAVAILABLE","occupationalCategory":"Medical & Clinical Lab Techs","@context":"http://schema.org","url":" **MEMBERS ONLY**SIGN UP NOW*** Last verified - 0 day(s) 14 hour(s) ago [ What does Last Verified mean? ] Job Feedback



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More